Search
Showing results for "clinical trials"
Two Perth clinician-scientists have been recognised as national leaders in infectious disease research after being elected as Fellows of the esteemed Australian Academy of Health and Medical Sciences.
Every year 650,000 Australian children suffer from recurrent or chronic middle ear infections called otitis media (OM).
Congratulations to six researchers from The Kids Research Institute Australia, who will use valuable support from the Raine Medical Research Foundation’s 2024 grant round to undertake projects focused on improving the health and wellbeing of babies, children and young people.
Two infectious disease researchers from Papua New Guinea (PNG) dedicated to reducing rates of childhood mortality in their home country are making significant advances thanks to support from the Deborah Lehmann Research Award (DLRA).
Papua New Guinean researcher Dr Lincoln Timinao has been awarded the 2025 Deborah Lehmann Research Award (DLRA) for his work aimed at investigating the burden of malaria in young children.
Australia's RSV Maternal and Infant Protection Program is delivering strong protection for babies, with new research from The Kids Research Institute Australia showing RSV vaccination given during pregnancy reduces the risk of RSV-related hospitalisation by more than 80 per cent during an infant's first six months
The teenage years can be a challenging time for families, a period made even more difficult if a child has type 1 diabetes.
A substantial funding boost from the Stan Perron Charitable Foundation will help to further extend one of Australia’s biggest longitudinal child health research studies centred around families from the Joondalup and Wanneroo communities.
Congratulations to three outstanding The Kids Research Institute Australia researchers who have received second chance WA health funding designed to support researchers who have narrowly missed out on highly competitive national funding.
It's been a huge year for those working to eliminate rheumatic heart disease (RHD), with breakthroughs including $35M in funding to develop a Strep A vaccine.